Mark Kieran, M.D. Ph.D.
Assistant Professor, Departments of Pediatrics and Hematology / Oncology, Harvard Medical School
Director, Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Institute
Instructor, Department of Pediatrics, Children’s Hospital Boston
Dr. Kieran received his PhD from the University of Alberta, Edmonton, Canada and his MD from the University of Calgary. He completed postgraduate training in molecular biology at the Pasteur Institute in Paris.
Dr. Kieran’s past research and publications have reported on anti-angiogenic cancer therapies. Mark Kieran’s laboratory in conjunction with the late Dr. Judah Folkman’s laboratory, have examined the anti-angiogenic effects of a number of angiogenic inhibitors including endostatin.
Dr. Kieran’s awards include the Nick Palmer Lecture Award received in London, England.